Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 20, 2020 01:25 ET | Source: Nyxoah

Nyxoah to Participate in Annual Piper Sandler Healthcare Conference

PRESS RELEASE Nyxoah to Participate in Annual Piper Sandler Healthcare Conference Mont-Saint-Guibert, Belgium – 20th November 2020 – Nyxoah S.A. (EBR: NYXH) (“Nyxoah” or the “Company”), a...
November 17, 2020 01:00 ET | Source: Nyxoah

First Patient Implanted in the DREAM US Pivotal IDE Study, with the Genio® System for the Treatment of Obstructive Sleep Apnea (OSA)

First Patient Implanted in the DREAM US Pivotal IDE Study, with the Genio® System for the Treatment of Obstructive Sleep Apnea (OSA) DREAM is a pivotal, Investigational Device Exemption (IDE) study,...
September 18, 2020 01:00 ET | Source: Nyxoah

Nyxoah Announces Commencement of Trading of Shares on Euronext Brussels

An investment in the Offered Shares involves substantial risks and uncertainties. Prospective investors should read the entire prospectus, and, in particular, should see "Risk Factors" for a...
September 17, 2020 08:41 ET | Source: Nyxoah

Nyxoah Raises up to €85 million (US$100m) in Successful Initial Public Offering

An investment in the Offered Shares involves substantial risks and uncertainties. Prospective investors should read the entire prospectus, and, in particular, should see "Risk Factors" for a...
August 27, 2020 01:00 ET | Source: Nyxoah

Nyxoah Announces Intention to Launch an Initial Public Offering on Euronext Brussels

An investment in the Offered Shares involves substantial risks and uncertainties. Prospective investors should read the entire prospectus, and, in particular, should see "Risk Factors" for a...
June 25, 2020 02:00 ET | Source: Nyxoah

Nyxoah receives IDE approval from the U.S. Food and Drug Administration (FDA) for its DREAM study

Nyxoah receives IDE approval from the U.S. Food and Drug Administration (FDA) for its DREAM study Study supporting the approval of Nyxoah’s Genio® system in the U.S. to be initiated in the coming...
November 27, 2019 02:00 ET | Source: Nyxoah

Nyxoah announces data demonstrating the benefits and safety of its Genio® system implantation technique for the treatment of Obstructive Sleep Apnea published in Laryngoscope Investigative Otolaryngology

Nyxoah announces data demonstrating the benefits and safety of its Genio® system implantation technique for the treatment of Obstructive Sleep Apnea published in Laryngoscope Investigative...
October 28, 2019 03:00 ET | Source: Nyxoah

Nyxoah publishes positive Obstructive Sleep Apnea data from BLAST OSA study in the European Respiratory Journal

Nyxoah publishes positive Obstructive Sleep Apnea data from BLAST OSA study in the European Respiratory Journal Compelling data published in prestigious journal show safety and efficacy of the...